3 results about "Tofacitinib" patented technology

Tofacitinib, sold under the brand Xeljanz among others, is a medication used to treat rheumatoid arthritis, psoriatic arthritis and ulcerative colitis. Common side effects include diarrhea, headache, and high blood pressure. Serious side effects may include infections, cancer, and pulmonary embolism. In 2019 EMA’s safety committee began a review of tofacitinib and has recommended that doctors temporarily not prescribe the 10 mg twice-daily dose to people at high risk for pulmonary embolism. The US Food and Drug Administration (FDA) has also released warnings about the risk of blood clots.